Bad news for Instagram models and aging Hollywood celebrities — Covid vaccines may make Botox wear off quicker.
Researchers found the average time that it took patients to need a top-up of the wrinkle-smoother shortened after they received the Pfizer mRNA vaccine.
Patients who previously returned every 118 days between injections were coming in around 20 days earlier. But doctors stressed it was not a reason not to get the vaccine.
Dermatologists in the US are reportedly seeing a similar trend among Botox users.
New York dermatologist Dr. Marisa Garshick addressed the topic in an Instagram reel last week.
‘Is the Covid vaccine why your Botox isn’t lasting as long?’ she asks in the short video, before flashing an image of the study.
In the accompanying caption, Dr. Garshick clarified that while some dermatologists – and patients – may have noticed this phenomenon in the office, ‘more research is needed to truly understand this observation’.
She also made sure to caveat that the potential cosmetic side-effect is not a reason to not get vaccinated.
Commenting on the post, popular skincare influencer Susan Yara said she too had experienced the quicker dissolving of her filler.
‘UGH!! I didn’t want this to be true, but it happened to me. I switched to Xeomin and it made a big difference’, she wrote beneath the video.
Injections generally last four to six months before a top-up is required to ensure a smooth complexion.
Botox is a brand name of botulinum toxin injectables.
They are injectable chemical class known as neuromodulators that interrupt signals between nerves and muscles to make them relax.
As a result, visible wrinkles will disappear.
These neuromodulators are typically used to treat the areas of the face between the eyebrows and in the corners of the eyes, as well as sometimes to plump the upper lip in a procedure called a ‘lip flip’.
The study looked at botulinum toxin injectables more generally – not just the popular Botox but also other newer neuromodulator treatments like Dysport, Xeomin, and Jeuveau.
Published in the Journal of Cosmetic Dermatology, the paper focused on 45 subjects, 89 percent female, with an average age of 48.3.
Because of the relatively small sample size, researchers clarified that their findings are inconclusive and called for additional research into the subject.
However, their results showed a marked decrease in the time it took patients to return to clinics needing Botulinum type A (BTA) top-up injections.